Bank of New York Mellon Corp - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 123 filers reported holding KALA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$4,000
-33.3%
19,0500.0%0.00%
Q2 2022$6,000
-97.2%
19,050
-87.5%
0.00%
Q1 2022$211,000
+12.2%
152,803
-1.3%
0.00%
Q4 2021$188,000
-62.0%
154,764
-18.1%
0.00%
Q3 2021$495,000
-47.9%
188,931
+5.4%
0.00%
Q2 2021$950,000
-17.5%
179,289
+4.9%
0.00%
Q1 2021$1,152,000
-2.8%
170,986
-2.1%
0.00%
Q4 2020$1,185,000
-14.3%
174,695
-5.2%
0.00%
Q3 2020$1,383,000
-42.3%
184,324
-19.1%
0.00%
-100.0%
Q2 2020$2,396,000
+72.7%
227,905
+44.3%
0.00%
Q1 2020$1,387,000
+333.4%
157,900
+82.8%
0.00%
Q4 2019$320,000
-13.7%
86,369
-11.5%
0.00%
Q3 2019$371,000
-26.7%
97,541
+23.1%
0.00%
Q2 2019$506,000
+4.3%
79,261
+35.1%
0.00%
Q1 2019$485,000
+71.4%
58,661
+1.3%
0.00%
Q4 2018$283,000
-27.2%
57,911
+46.8%
0.00%
Q3 2018$389,000
-31.5%
39,447
-4.5%
0.00%
Q2 2018$568,000
+7.0%
41,327
+23.2%
0.00%
Q1 2018$531,000
+29.8%
33,543
+51.6%
0.00%
Q4 2017$409,000
-24.3%
22,127
-6.3%
0.00%
Q3 2017$540,00023,6260.00%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Vahanian & Associates Financial Planning Inc. 181,384$54,0000.23%
Samsara BioCapital, LLC 601,162$180,0000.05%
Board of Trustees of The Leland Stanford Junior University 688,701$207,0000.01%
Matisse Capital 36,800$11,0000.01%
Knights of Columbus Asset Advisors LLC 120,841$36,0000.00%
Covestor Ltd 11,972$4,0000.00%
Ergoteles LLC 219,461$66,0000.00%
Virtu Financial LLC 74,636$22,0000.00%
IPG Investment Advisors LLC 14,300$4,0000.00%
Aquatic Capital Management LLC 13,200$4,0000.00%
View complete list of KALA PHARMACEUTICALS INC shareholders